TY - JOUR
T1 - Prevalencia y factores asociados a la intención de vacunarse contra la COVID-19 en el Perú
AU - Herrera-Añazco, Percy
AU - Uyen-Cateriano, Ángela
AU - Urrunaga-Pastor, Diego
AU - Bendezu-Quispe, Guido
AU - Toro-Huamanchumo, Carlos J
AU - Rodríguez-Morales, Alfonso J
AU - Hernández, Adrian V
AU - Benites-Zapata, Vicente A
N1 - Publisher Copyright:
© 2021, Instituto Nacional de Salud. All rights reserved.
PY - 2021/12/22
Y1 - 2021/12/22
N2 - OBJECTIVES: To estimate the prevalence and factors associated with the intention to be vaccinated (ITV) against COVID-19 in Peru.MATERIALS AND METHODS: Analytical cross-sectional study using the survey conducted by the University of Maryland, USA, on Facebook. The dependent variable is the ITV. Crude and adjusted prevalence ratios (PR) were calculated, with their 95% confidence intervals (95% CI) using generalized linear models of the Poisson family, in order to evaluate the association of sociodemographic variables, compliance with community mitigation strategies, symptoms of COVID-19, mental health and acceptance of vaccination before the recommendation (AVR) by various actors and health authorities, with the ITV.RESULTS: Data from 17,162 adults were analyzed. The overall prevalence of the ITV was 74.9%. A lower prevalence of the ITV was associated with the female sex (PR=0.95; 95% CI: 0.94-0.97), living in a town (PR=0.95; 95% CI: 0.91-0.99) or village or other rural area (PR=0.90; 95% CI: 0.86-0.93) and the AVR of politicians (PR=0.89; 95% CI: 0.87-0.92). Conversely, having COVID-19 symptoms (PR=1.06; 95% CI: 1.03-1.09), economic insecurity (PR=1.04; 95% CI: 1.01-1.06), fears of becoming seriously ill or that a family member becomes seriously ill from COVID-19 (PR=1.49; 95% CI: 1.36-1.64) and the AVR of family and friends (PR=1.10; 95% CI: 1.08-1.12), healthcare workers (PR=1.29; 95% CI: 1.26-1.32), World Health Organization (PR=1.34; 95% CI: 1.29-1.40) and government officials (PR=1.18; 95% CI: 1.15-1.22) was associated with a higher prevalence of the ITV.CONCLUSIONS: Three-quarters of the respondents had the ITV. There are potentially modifiable factors that could improve vaccine acceptance.
AB - OBJECTIVES: To estimate the prevalence and factors associated with the intention to be vaccinated (ITV) against COVID-19 in Peru.MATERIALS AND METHODS: Analytical cross-sectional study using the survey conducted by the University of Maryland, USA, on Facebook. The dependent variable is the ITV. Crude and adjusted prevalence ratios (PR) were calculated, with their 95% confidence intervals (95% CI) using generalized linear models of the Poisson family, in order to evaluate the association of sociodemographic variables, compliance with community mitigation strategies, symptoms of COVID-19, mental health and acceptance of vaccination before the recommendation (AVR) by various actors and health authorities, with the ITV.RESULTS: Data from 17,162 adults were analyzed. The overall prevalence of the ITV was 74.9%. A lower prevalence of the ITV was associated with the female sex (PR=0.95; 95% CI: 0.94-0.97), living in a town (PR=0.95; 95% CI: 0.91-0.99) or village or other rural area (PR=0.90; 95% CI: 0.86-0.93) and the AVR of politicians (PR=0.89; 95% CI: 0.87-0.92). Conversely, having COVID-19 symptoms (PR=1.06; 95% CI: 1.03-1.09), economic insecurity (PR=1.04; 95% CI: 1.01-1.06), fears of becoming seriously ill or that a family member becomes seriously ill from COVID-19 (PR=1.49; 95% CI: 1.36-1.64) and the AVR of family and friends (PR=1.10; 95% CI: 1.08-1.12), healthcare workers (PR=1.29; 95% CI: 1.26-1.32), World Health Organization (PR=1.34; 95% CI: 1.29-1.40) and government officials (PR=1.18; 95% CI: 1.15-1.22) was associated with a higher prevalence of the ITV.CONCLUSIONS: Three-quarters of the respondents had the ITV. There are potentially modifiable factors that could improve vaccine acceptance.
KW - COVID-19
KW - COVID-19 Vaccines
KW - Peru (source: MeSH NLM)
KW - SARS-Co-V2
KW - Vaccination
KW - Vaccination Refusal
UR - http://www.scopus.com/inward/record.url?scp=85122152229&partnerID=8YFLogxK
U2 - 10.17843/RPMESP.2021.383.7446
DO - 10.17843/RPMESP.2021.383.7446
M3 - Artículo
C2 - 34932739
AN - SCOPUS:85122152229
SN - 1726-4634
VL - 38
SP - 381
EP - 390
JO - Revista Peruana de Medicina Experimental y Salud Publica
JF - Revista Peruana de Medicina Experimental y Salud Publica
IS - 3
ER -